Shares of Boston Scientific Corp. BSX slid 1.03% to $103.10 Tuesday, on what proved to be an all-around positive trading ...

With a market cap of $155.7 billion, Boston Scientific Corporation (BSX) is a global medical device company operating through ...

Boston Scientific will eliminate jobs after discontinuing global sales of its Acurate aortic valve replacement systems that ...

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement ...

Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves ...

Camille Chang Gilmore, Boston Scientific’s global chief DEI officer announced she is leaving the company after two decades of ...

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...

Boston Scientific leads in MedSurg and Cardiovascular with strong Q1 growth, solid margins, and smart acquisitions. Find out ...

Boston Scientific Corp. closed 2.80% short of its 52-week high of $107.17, which the company achieved on February 5th.